Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:3322

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rechavia, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rechavia, E.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Nuclear cardiology and PET
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 1999;99:3322.)
© 1999 American Heart Association, Inc.


Images in Cardiovascular Medicine

Myocardial [18F]Fluorodeoxyglucose Uptake After Heterotopic Cardiac Transplantation Assessed by Positron Emission Tomography

Eldad Rechavia, MD

From the Cardiology Division, Rabin Medical Center Beilinson Campus, Tel Aviv University Sackler School of Medicine, Israel, and the Cyclotron Unit Medical Research Council Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Correspondence to Dr Eldad Rechavia, Cardiology Division, Rabin Medical Center Beilinson Campus, Petach Tikva 49100, Israel.

Metabolic aspects, perfusion autoregulation, and receptor-mediated cardiac responses of the orthotopic cardiac transplant have gained increasing attention in the past few years. We recently assessed glucose uptake in vivo in orthotopic heart transplant recipients.1 Enhanced myocardial uptake as demonstrated by [18F]2-fluoro-2-deoxyglucose (18FDG) and PET scanning was explained by inefficient metabolic utilization of glucose by the transplanted myocardium or by the influence of circulating catecholamines, which may stimulate glucose uptake independently of cardiac workload. We also studied a 48-year-old male patient 6 months after heterotopic heart transplantation. Glucose uptake was assessed by use of 18FDG and PET imaging, with the basic premise that this parameter gives direct evidence of glucose metabolic state and myocardial viability in both cardiac allograft and the native poorly contracting heart, which was left in situ. Regional 18FDG uptake (mL · s-1 · g-1) was defined as the ratio of the average 18FDG pixel counts in the various tissue regions of the left ventricle to the integral of the arterial input function, as previously described.1 Regional 18FDG uptake was on average 285% higher in the transplanted heart than in the native heart (FigureDown). This stems largely from the difference in myocardial tissue viability, as well as probably reflecting functional-metabolic coupling of the transplanted heart as opposed to the native heart.



View larger version (73K):
[in this window]
[in a new window]
 
Figure 1. Serial transaxial PET images from a patient after heterotopic heart transplantation. 18FDG scan, obtained 60 minutes after tracer injection, outlines difference in metabolic activity between native and transplanted hearts. From apex to base, each section contains native and transplanted hearts located on left and right sides, respectively. Left ventricular cavity of native heart is markedly dilated. 18FDG images reveal an extensive reduction of uptake throughout entire left ventricular myocardium, with severely reduced activity in apical and septal segments, corresponding to an old infarction. By contrast, myocardial glucose utilization of transplanted heart is well preserved, as indicated by homogeneous enhanced uptake of 18FDG. Note prominent activity in mid ventricular segments (top right sections), corresponding to papillary muscles.

Footnotes

The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.

Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's Episcopal Hospital and Texas Heart Institute, 6720 Bertner Ave, MC1-267, Houston, TX 77030.

References

1. Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol. 1997;30:533–538.[Abstract]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rechavia, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rechavia, E.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Nuclear cardiology and PET
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy